• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与尿液细胞学检查相比,多探针荧光原位杂交检测法在检测膀胱癌及其复发的排尿标本中的临床应用价值。

Clinical utility of a multiprobe FISH assay in voided urine specimens for the detection of bladder cancer and its recurrences, compared with urinary cytology.

作者信息

Placer José, Espinet Blanca, Salido Marta, Solé Francesc, Gelabert-Mas Antoni

机构信息

Department of Urology, Hospital del Mar, IMAS, Passeig Maritim 25-29, 08003 Barcelona, Spain.

出版信息

Eur Urol. 2002 Dec;42(6):547-52. doi: 10.1016/s0302-2838(02)00448-7.

DOI:10.1016/s0302-2838(02)00448-7
PMID:12477649
Abstract

OBJECTIVES

To evaluate the clinical utility of a Multi-color FISH (fluorescence in situ hybridization) assay in voided urine specimens for the detection of bladder cancer and its recurrences, comparing the results with those afforded by urinary cytology.

METHODS

Voided urine samples from 86 patients were obtained for urine cytology and FISH analysis. The latter was performed using a mixture of fluorescent labeled DNA probes for the centromeric regions of chromosomes 3, 7 and 17, and the 9p21 region. Cystoscopy with biopsy or tumor resection was performed in all patients, comparing the pathological results with the cytological and FISH findings.

RESULTS

Urinary cytology affords an overall sensitivity of 63.8%, the figure being 25% for grade 1, 66.6% for grade 2 and 94.7% for grade 3 tumors. The sensitivities for FISH were 53.3% for grade 1, 83.3% for grade 2 and 100% for grade 3 tumors, with an overall sensitivity of 80.4%. The specificities of urinary cytology and FISH were 86.1 and 85.3%, respectively.

CONCLUSIONS

FISH improves the sensitivity rates obtained with urine cytology for bladder cancer detection in all tumor grades and stages, and offers similar specificity. FISH doubles the accuracy of urinary cytology in application to low grade-stage tumors, and detects all high grade infiltrating tumors.

摘要

目的

评估多色荧光原位杂交(FISH)检测法在检测膀胱癌及其复发的晨尿样本中的临床效用,并将结果与尿细胞学检测结果进行比较。

方法

收集86例患者的晨尿样本进行尿细胞学和FISH分析。FISH分析采用荧光标记的DNA探针混合物,针对染色体3、7和17的着丝粒区域以及9p21区域。所有患者均接受膀胱镜检查及活检或肿瘤切除术,并将病理结果与细胞学和FISH检查结果进行比较。

结果

尿细胞学检测的总体敏感性为63.8%,其中1级肿瘤的敏感性为25%,2级肿瘤为66.6%,3级肿瘤为94.7%。FISH检测1级肿瘤的敏感性为53.3%,2级肿瘤为83.3%,3级肿瘤为100%,总体敏感性为80.4%。尿细胞学和FISH检测的特异性分别为86.1%和85.3%。

结论

FISH提高了尿细胞学检测在所有肿瘤分级和分期中检测膀胱癌的敏感性,且特异性相似。FISH使尿细胞学检测在应用于低分级低分期肿瘤时的准确性提高了一倍,并能检测出所有高分级浸润性肿瘤。

相似文献

1
Clinical utility of a multiprobe FISH assay in voided urine specimens for the detection of bladder cancer and its recurrences, compared with urinary cytology.与尿液细胞学检查相比,多探针荧光原位杂交检测法在检测膀胱癌及其复发的排尿标本中的临床应用价值。
Eur Urol. 2002 Dec;42(6):547-52. doi: 10.1016/s0302-2838(02)00448-7.
2
Fluorescence in situ hybridization performed on exfoliated urothelial cells in patients with transitional cell carcinoma of the bladder.对膀胱移行细胞癌患者的脱落尿路上皮细胞进行荧光原位杂交。
Urology. 2004 Feb;63(2):398-401. doi: 10.1016/j.urology.2003.08.026.
3
Noninvasive detection and prediction of bladder cancer by fluorescence in situ hybridization analysis of exfoliated urothelial cells in voided urine.通过对晨尿中脱落尿路上皮细胞进行荧光原位杂交分析对膀胱癌进行无创检测和预测。
Urology. 2001 Apr;57(4):811-5. doi: 10.1016/s0090-4295(00)01074-8.
4
[Numerical aberrations of chromosomes 11 and 17 detected by fish--fluorescence in situ hybridization combined with cytology in exfoliated cells from voided urine in patients with urothelial carcinoma of the bladder].[应用荧光原位杂交技术结合膀胱尿路上皮癌患者晨尿脱落细胞的细胞学检查检测11号和17号染色体的数值畸变]
Harefuah. 2007 Dec;146(12):914-9, 1000.
5
Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings.多探针荧光原位杂交技术用于增强对排尿标本和膀胱冲洗液中膀胱癌的检测。
Am J Clin Pathol. 2001 Jul;116(1):79-86. doi: 10.1309/K5P2-4Y8B-7L5A-FAA9.
6
Multitarget fluorescence in situ hybridization assay detects transitional cell carcinoma in the majority of patients with bladder cancer and atypical or negative urine cytology.多靶点荧光原位杂交检测法可在大多数膀胱癌且尿液细胞学检查不典型或呈阴性的患者中检测出移行细胞癌。
J Urol. 2003 Jun;169(6):2101-5. doi: 10.1097/01.ju.0000066842.45464.cc.
7
The role of fluorescence in situ hybridization assay for surveillance of non-muscle invasive bladder cancer.荧光原位杂交检测在非肌层浸润性膀胱癌监测中的作用。
Can J Urol. 2010 Apr;17(2):5077-81.
8
Evaluation of DD23 as a marker for detection of recurrent transitional cell carcinoma of the bladder in patients with a history of bladder cancer.评估DD23作为膀胱癌病史患者复发性膀胱移行细胞癌检测标志物的价值。
Urology. 2003 Mar;61(3):539-43. doi: 10.1016/s0090-4295(02)02400-7.
9
Utility of a multiprobe fluorescence in situ hybridization assay in the detection of superficial urothelial bladder cancer.多探针荧光原位杂交检测法在浅表性膀胱尿路上皮癌检测中的应用
Cancer Genet Cytogenet. 2007 Mar;173(2):131-5. doi: 10.1016/j.cancergencyto.2006.10.011.
10
Surveillance of patients with bladder carcinoma using fluorescent in-situ hybridization on bladder washings.使用荧光原位杂交技术对膀胱癌患者的膀胱冲洗液进行监测。
BJU Int. 2008 Jan;101(1):26-9. doi: 10.1111/j.1464-410X.2007.07183.x. Epub 2007 Sep 10.

引用本文的文献

1
Identification of novel protein biomarkers from the blood and urine for the early diagnosis of bladder cancer via proximity extension analysis.通过邻近延伸分析从血液和尿液中鉴定新型膀胱癌早期诊断的蛋白质生物标志物。
J Transl Med. 2024 Mar 26;22(1):314. doi: 10.1186/s12967-024-04951-z.
2
Preoperative fluorescence in situ hybridization analysis as a predictor of tumor recurrence in patients with non-muscle invasive bladder cancer: a bi-institutional study.术前荧光原位杂交分析预测非肌肉浸润性膀胱癌患者肿瘤复发:一项双机构研究。
J Transl Med. 2023 Oct 2;21(1):685. doi: 10.1186/s12967-023-04528-2.
3
SUMOylation promotes extracellular vesicle-mediated transmission of lncRNA ELNAT1 and lymph node metastasis in bladder cancer.
小泛素样修饰促进细胞外囊泡介导的长链非编码RNA ELNAT1传递及膀胱癌淋巴结转移。
J Clin Invest. 2021 Apr 15;131(8). doi: 10.1172/JCI146431.
4
Association of chromosome 7 aneuploidy measured by fluorescence in situ hybridization assay with muscular invasion in bladder cancer.荧光原位杂交检测 7 号染色体非整倍体与膀胱癌肌层浸润的相关性。
Cancer Commun (Lond). 2020 Apr;40(4):167-180. doi: 10.1002/cac2.12017. Epub 2020 Apr 12.
5
A comprehensive comparison of fluorescence in situ hybridization and cytology for the detection of upper urinary tract urothelial carcinoma: A systematic review and meta-analysis.荧光原位杂交与细胞学检查在上尿路尿路上皮癌检测中的综合比较:一项系统评价与荟萃分析
Medicine (Baltimore). 2018 Dec;97(52):e13859. doi: 10.1097/MD.0000000000013859.
6
UroVysion fluorescence in situ hybridization (UroVysion FISH) assay for detection of bladder cancer in voided urine of Turkish patients: a preliminary study.用于检测土耳其患者晨尿中膀胱癌的UroVysion荧光原位杂交(UroVysion FISH)检测:一项初步研究。
Contemp Oncol (Pozn). 2013;17(2):156-60. doi: 10.5114/wo.2013.34619. Epub 2013 Apr 29.
7
Selection of microsatellite markers for bladder cancer diagnosis without the need for corresponding blood.用于膀胱癌诊断的微卫星标志物选择,无需相应的血液样本。
PLoS One. 2012;7(8):e43345. doi: 10.1371/journal.pone.0043345. Epub 2012 Aug 22.
8
The value of the preoperative FISH test in unscreened bladder cancer patients with TUR indications.术前 FISH 检测在有 TUR 适应证的未经筛查膀胱癌患者中的价值。
Pathol Oncol Res. 2012 Oct;18(4):1059-66. doi: 10.1007/s12253-012-9544-6. Epub 2012 Jun 23.
9
The role of FISH and cytology in upper urinary tract surveillance after radical cystectomy for bladder cancer.膀胱癌根治性膀胱切除术后上尿路监测中 FISH 和细胞学的作用。
Urol Oncol. 2012 Nov-Dec;30(6):821-4. doi: 10.1016/j.urolonc.2010.08.006. Epub 2011 Mar 10.
10
Urine cytology and adjunct markers for detection and surveillance of bladder cancer.用于膀胱癌检测和监测的尿液细胞学及辅助标志物。
Am J Transl Res. 2010 Jul 25;2(4):412-40.